Delivery Order SPE2DB20D9226-SPE2DB22FQ59C
Award Date 4/14/22
Potential Completion Date 4/15/22
Potential Value $1.6K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the SPE2DB program administered by the Defense Logistics Agency (DLA), a defense agency. The $2,444.40 firm fixed-price contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract with the DLA valued at up to $499,999,999, which allows the agency to issue delivery orders...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The contract is a firm fixed-price delivery order valued at $7,333.20, with an ultimate completion date of January 6, 2022. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The award is a firm fixed-price delivery order, with no set-aside designation, valued at $7,333.20. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the issuance of delivery orders for a comprehensive range of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides the Defense Logistics Agency (DLA) with delivery orders for NARCAN 4 MG NASAL SPRAY 2S medication. The contract, valued at $1,625.76, is a firm fixed-price delivery order with a completion date of June 16, 2022. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The contract, valued at $4,074.00, is for the supply of NARCAN 4 MG NASAL SPRAY 2S to support the medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical consumables to the Department of...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB Indefinite Delivery Contract (IDC). The $1,629.60 firm fixed-price award is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a prescription medication. The IDC allows the DLA to issue delivery orders for a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications,...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $4,074.00 under the Defense Logistics Agency's (DLA) SPE2DB program. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the DLA's SPE2DB program. The contract is for the delivery of 4,554,970,111 units of NARCAN 4 mg Nasal Spray, a critical opioid overdose treatment medication, to support the recurring medical supply needs of military health facilities. The firm fixed-price contract, valued at $4,888.80, has an ultimate completion date of September 29, 2021. DMS...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $6,518.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds...
- This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of NARCAN 4 MG NASAL SPRAY 2S to the Defense Logistics Agency (DLA). The $1,424.52 firm fixed-price delivery order is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue firm fixed-price delivery orders for a wide...